At Alumis, our goal is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.

We recognize that patients living with immune-mediated diseases need alternatives to currently available therapies. Despite recent advances and innovations in the treatment of immune-mediated diseases, many patients continue to suffer, cycling through currently approved therapies while looking for a solution that alleviates the debilitating impact of their disease without life-limiting side effects. 

Addressing the needs of these patients is why we exist. We are pioneering a precision approach that leverages insights we derive from powerful data analytics to select the right target, right molecule, right indication, right patient, and right endpoint resulting in optimized outcomes for patients. We believe that combining our insights with an integrated approach to drug development will produce the next generation of treatments to address immune dysfunction. 

Incubated by Foresite Labs, Alumis is led by a team of deeply experienced professionals who are devoted to transforming the lives of patients with immune-mediated diseases by developing a pipeline of transformative therapies.

Health Care

Life Sciences

Therapeutics

Alumis

Martin Babler

Tori Lovell

Alexis Brayton

Melissa Ceo

Grace Halteh

Director, Regulatory Strategy

Lily Gong

Jennifer Cortes

Kolbot By

Tim Owens

Derrick Richardson

Alan Colowick

Roy Hardiman

Mark Bradley

Jörn Drappa

John Schroer

David M Goldstein

The Clinical and Development Operations team at Alumis is responsible for overseeing the planning, execution, and analysis of clinical trials and drug development processes. This involves managing clinical trial operations, ensuring regulatory compliance, and harnessing data insights to inform development strategies. The team collaborates to optimize outcomes by selecting the right targets, molecules, indications, and patient endpoints, ultimately delivering transformative therapies for those with immune-mediated diseases.

Clinical and Development Operations

Leadership Team

Research and Development

Clinical and Development Operations

About

Team members

Other teams at Alumis

Leadership Team

Research and Development